Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer
Status:
Unknown status
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
Objectives:
To evaluate the safety and effectiveness of cell therapy using Precision Cell Immunotherapy
to treat Advanced Gastric Cancer.
Eligibility:
Individuals greater than or equal to 18 years of age and less than or equal to 65 years of
age who have been diagnosed with Advanced Gastric Cancer.